Our previous studies showed that the (+)-isomers of naloxone and naltrexone (that do not act on opioid receptors) suppress elevation of dopamine in the nucleus accumbens by cocaine and morphine by a Toll-4/MD2 dependent mechanism. In the present work, we used intracellular recording of evoked GABAergic inhibitory postsynaptic potentials (eIPSPs) in central amygdala (CeA) neurons to examine the role of TLR4 activation by lipopolysaccharide (LPS). We also studied deletion of the LPS adapter protein CD14 in acute ethanol effects on the GABAergic system. Using a combination of pharmacological blockade of the Toll-4/MD2 system and CD14 knockout mice, we showed that TLR4/MD2 and CD14 play a substantial role in the acute effects of ethanol and suggesting that drugs acting on these two systems may be useful agents for the treatment of alcohol abuse. Earlier work has implicated neurokinin-1 receptors (NK1Rs) in the mediation of alcohol and opiate, but not cocaine reward in rodents. We showed earlier that NK1R antagonism also blocks stress-induced reinstatement of alcohol seeking in rats. Other studies have found that substance P (SP) infusion directly into the brain reinstates cocaine seeking following extinction. We earlier synthesized the NK1R antagonist L822429 and have now utilized this antagonist to examine the question of whether on yohimbine-induced reinstatement of alcohol or cocaine seeking can be blocked with L822429 in the rat. We found that L822429 attenuates yohimbine-induced reinstatement of alcohol seeking, but does not affect baseline alcohol self-administration. Our studies also showed that L822429 suppresses of yohimbine-induced reinstatement of cocaine seeking by L822429, suggesting that the NK1R receptor is involved in stress-induced seeking of both drugs.

Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
2014
Total Cost
Indirect Cost
Name
National Institute on Drug Abuse
Department
Type
DUNS #
City
State
Country
Zip Code
Ayanwuyi, Lydia O; Stopponi, Serena; Ubaldi, Massimo et al. (2015) Neurokinin 1 receptor blockade in the medial amygdala attenuates alcohol drinking in rats with innate anxiety but not in Wistar rats. Br J Pharmacol 172:5136-46
Schank, J R; Nelson, B S; Damadzic, R et al. (2015) Neurokinin-1 receptor antagonism attenuates neuronal activity triggered by stress-induced reinstatement of alcohol seeking. Neuropharmacology 99:106-14
Blasio, Angelo; Valenza, Marta; Iyer, Malliga R et al. (2015) Sigma-1 receptor mediates acquisition of alcohol drinking and seeking behavior in alcohol-preferring rats. Behav Brain Res 287:315-22
Corrigan, Frances; Wu, Yue; Tuke, Jonathan et al. (2015) Alcohol-induced sedation and synergistic interactions between alcohol and morphine: a key mechanistic role for Toll-like receptors and MyD88-dependent signaling. Brain Behav Immun 45:245-52
Augier, E; Flanigan, M; Dulman, R S et al. (2014) Wistar rats acquire and maintain self-administration of 20 % ethanol without water deprivation, saccharin/sucrose fading, or extended access training. Psychopharmacology (Berl) 231:4561-8
Bajo, Michal; Madamba, Samuel G; Roberto, Marisa et al. (2014) Innate immune factors modulate ethanol interaction with GABAergic transmission in mouse central amygdala. Brain Behav Immun 40:191-202
Schank, Jesse R; King, Courtney E; Sun, Hui et al. (2014) The role of the neurokinin-1 receptor in stress-induced reinstatement of alcohol and cocaine seeking. Neuropsychopharmacology 39:1093-101
Sabino, Valentina; Kwak, Jina; Rice, Kenner C et al. (2013) Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking. Alcohol Clin Exp Res 37:635-43
Schank, Jesse R; Tapocik, Jenica D; Barbier, Estelle et al. (2013) Tacr1 gene variation and neurokinin 1 receptor expression is associated with antagonist efficacy in genetically selected alcohol-preferring rats. Biol Psychiatry 73:774-81
Lewis, Susannah S; Hutchinson, Mark R; Zhang, Yingning et al. (2013) Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain. Brain Behav Immun 30:24-32

Showing the most recent 10 out of 17 publications